In a recent study, researchers utilized RiskReveal, a 14-gene expression profile, to pinpoint patients with stage IA-IIA nonsquamous NSCLC who could benefit from adjuvant therapy. Among the 194 evaluable patients, 87 received therapy post-surgery, while 107 were observed. Notably, 55% in each arm had stage IA disease, with well-matched demographics and tumor characteristics. This approach […]
Category: personalized cancer vaccines
Advances in Personalized Cancer Treatment
Cancer survivors are celebrating the progress in personalized treatment through precision medicine, utilizing targeted radiation and customized medication. Dr. Michael Gieske, from St. Elizabeth Healthcare, sheds light on the intricacies of this tailored approach, showcasing how it enhances individual care journeys. With a focus on precision and individual needs, personalized cancer treatment is revolutionizing patient […]
Debunking Turbo Cancer Myths by Makis: A Quack Exposed
The ‘turbo cancer’ myth, propagated by Dr. William Makis, a delicensed radiologist turned oncologist, has been debunked. Makis falsely claims that COVID-19 vaccines cause ‘turbo cancers,’ which are supposedly faster-growing and malignant. Despite lacking evidence, he promotes unproven treatments like ivermectin, fenbendazole, and mebendazole for cancer. This exposes the dangers of misinformation in cancer care […]
